ERBB2 and breast cancer: To this aim we took advantage of the pipeline we previously developed and used for the identification of murine Her2+ breast CSC antigens [16], based on the comparison of the gene expression profiles of breast cancer cells cultured in vitro in adherent and non-adherent conditions.